Skip to content

Clinical trials

Completed Phase 1 Attention Deficit Disorder with Hyperactivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Phase 1 Status: Completed Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20052
20081
20095
20104
20113
20134
20142
20153
20162
20174
20184
20193
20203
20212
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.7
Shire4
PhenoSolve, LLC3
Aevi Genomic Medicine, LLC, a Cerecor company2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Massachusetts General Hospital2
Spanish Foundation for Neurometrics Development2
The National Center on Addiction and Substance Abuse at Columbia University2
Vallon Pharmaceuticals, Inc.2
Yale University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity52
Conduct Disorder2
Narcolepsy2
Oppositional Defiant Disorder2
Alcoholism1
Autism Spectrum Disorder1
Autistic Disorder1
Binge-Eating Disorder1
Borderline Personality Disorder1
Central Nervous System Diseases1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.